|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus显示文摘 | Davey RA Tebbutt NC Favaloro JM | 2006 | Lipids Health Dis2006，5，： | 1 |
| 2 | Towards the biomarker - guided rational use of antiangiogenie agents in the treatment of metastatic color- ectal cancer 显示文摘 | Halford MM Tebbutt NC Desai J | 2012 | Colorectal Cancer2012，1，2： | 1 |
| 3 | Randomized, muhicenter phase Ⅲ study comparing capecitabine with fluorouracil and oxaliphain with cisplatin in patients with advanced oesophago - gastric cancers:Interim analysis显示文摘 | Tebbutt NC | 2002 | Proc Am Soc Cli Oncol2002，21，： | 1 |
| 4 | Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus 显示文摘 | Davey RA Tebbutt NC | 2006 | Lipids Health Dis2006，5，： | 1 |
| 5 | Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases显示文摘 | Tebbutt NC Norman AR Cunningham D | | 0，，04： | 1 |
| 6 | Strate-gies for overcoming inherent and acquired resistance to EGFR in-hibitors by targeting downstream effectors in the RAS/PI3K path-way 显示文摘 | WEICKHARDT AJ TEBBUTT NC MARIADASON JM | 2010 | Curr Cancer Drug Tar2010，10，8： | 1 |
| 7 | Towards the biomarker-guided rational use of antiangiogenic agents in the treatment of metastatic colorectal cancer显示文摘 | HALFORD MM TEBBUTT NC DESAI J | 2012 | Colorectal Cancer2012，1，2： | 1 |
| 8 | Randomised, non- compartive Phase II study of weekly docetaxel with eisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AG1TG TTAX trial显示文摘 | Tebbutt NC Cummins MM Sourjina T | 2010 | Br J Cancer2010，102，： | 1 |
| 9 | Randomised non- comparative phase Ⅱ study of weekly docetaxel with cisplatin and 5- fluorouracil or with capecitabine in oesophagogastrie cancer:the AGITG ATI'AX trial显示文摘 | Tebbutt NC Cummins MM ourjina TS | 2010 | Bfit J Cancer2010，102，3： | 1 |
| 10 | Severe com- bined hyperlipid aemia and retinal lipid infiltration in a pa-tient with Type 2 diabetes mellitus显示文摘 | Davey RA Tebbutt NC Favaloro JM | 2006 | Lipids Health Dis2006，17，5： | 1 |
| 11 | Efficacyand safety of bevacizumab in metastatic colorec-tal cancer: pooled analysis from seven randomizedcontrol led trials 显示文摘 | Hurwitz HI Tebbutt NC Kabbinavar F | 2013 | Oncologist2013，18，9： | 1 |
| 12 | Capecitabine,bevacizumab,and mitomycin in first-line treatment of metastatic colorectal cancer:re-sults of the Australasian Gastrointestinal Trials Group Randomized Phase Ⅲ MAX Study显示文摘 | Tebbutt NC Wilson K Gebski VJ | | 0，，： | 1 |
| 13 | Severe combined hyperlipid aemia and retinal lipid infiltration in a patient with Type 2diabetes显示文摘 | Davey RA Tebbutt NC Favaloro JM | 2006 | Lipids Health Dis2006，17，5： | 1 |
| 14 | Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases显示文摘 | Tebbutt NC Norman AR Cunningham D | 2003 | Gut2003，52，4： | 1 |
| 15 | Phase II1 , randomized, double-blind, mnlticenter, placebo (P)- controlled trial of Rilotumumab (R) plus Epirubicin, Cisplatin and C apecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 study显示文摘 | Cunningham D Tebbutt NC Davidenko I | 2015 | J Clin Oncol (Meeting Abstracts)2015，33，15： | 1 |
| 16 | Intestinal complications after chemotherapy for patients with unreseeted primary coloreetal cancer and synchronous metastases 显示文摘 | Tebbutt NC Norman AR Cunningham D | 2003 | Gut2003，52，4： | 1 |
| 17 | Randomized,multicenter phase III study comparing capecitabine with fluorouracil and oxalipltain with cisplatin in patients with advanced oesophago-gastric cancers:Interim analysis显示文摘 | Tebbutt NC | 2002 | Proc Am Soc Clin Oncol2002，21，： | 1 |
| 18 | Randomised,non-comparative phase II study of weekly docetaxel with cisplatinand 5-fluorouracil or with capecitabine in oesophagogastric canc-er:the AGITG A1TAX trial显示文摘 | Tebbutt NC Cummins MM Sourjina T | 2010 | Br J Cancer2010，102，3： | 1 |
| 19 | A multicente,randomized phase Ⅲ trial comparing protracted venous infusion(PVI)5-fuorouracil with PVI plus mitomycin C in patients with inoperable oesophago-gastric cancer显示文摘 | Tebbutt NC Norman A Cunningham D | 2002 | Ann Onco12002，13，9： | 1 |
| 20 | Systemic treatment of colorectal cancer显示文摘 | Tebbutt NC Cattell E Midgleym R | 2002 | EurJ Cancer2002，38，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员